Professional Documents
Culture Documents
Absi, Adelstein, Rice. 2010. Esophageal Cancer. The Cleveland Clinic
Absi, Adelstein, Rice. 2010. Esophageal Cancer. The Cleveland Clinic
at:
http://muslimafiyah.com/orang-yang-sakit-selayaknya-
at:
http://csbl.bmb.uga.edu/mirrors/JLU
34. Park JC, Moon C. 2008. Gene therapy for esophageal cancer. Cancer
Therapy Vol.6,35-46,2008.
35. Pat J, Gold JS, unshi NC, Shammas MA. 2013. Biology of telomeres:
Importance in etiology of esophageal cancer and as therapeutic target.
Transl Res. 2013 December; 162(6).
36. Rauschhuber CT. 2011. Analysis of adenovirus-host interactions to
improve recombinant adenoviral vectors for gene therapy. LudwigMaximillians University: Munich.
37. Robert, Michel, Flaman, et al. 2000. High frequency of esophageal
Cancer of p53 alterations inactivating the regulation of genes involved in
cell cycle and apoptosis. Carcinogenesis, 21,563-565.
38. Ross PJ, Parks RJ. 2009. Construction and characterization of adenovirus
vectors. Cold Spring Harb ProtocVol. 4, issue 5, May 2009.
39. Roy Chowdury J, Horwitz MS. 2002. Evolution of adenovirus as gene
therapy vectors. Molecular Therapy Vol.5, No.4, April 2002.
40. Sharma A, Li X, Bangari DS, Mittal SK. 2009. Adenovirus receptors and
their implications in gene delivery. Virus Res. 2009 August; 143(2):184194.
41. Shimada H, Matsubara H, Shiratori T, Shimizu T, Miyazaki S, Okazumi
S, Nabeya Y, Shuto K, Hayashi H, Tanizawa T, Nakatani Y, Nakasa H,
Kitaada M, Ochiai T. 2006. Phase I/II adenoviral p53 gene therapy for
chemoradiation resistant advanced esophageal squamous cell carcinoma.
Cancer Sci, Vol. 97, No.6, June 2006: 554-561.
42. Shors, Teri. 2011. Understanding viruses, 2nd ed. USA: Jones & Bartlett
Learning, LLC.
43. Stahl, et al. 2010. Esophageal cancer: Clinical Practice Guidelines for
diagnosis, treatment and follow-up. Annals of Oncology 21 (supplement
5):v46-v49 (2010).
44. Sun YL, Xie H, Lin HL, Feng Q, Lin Y. 2015. Construction and
identification of recombinant adenovirus carrying human TIMP-1shRNA
gene. Genetics and Molecular Research 14 (1):199 208 (2015).
45. Tan R, Li C, Jiang S, Ma L. 2006. A novel and simple method for
construction of recombinant adenoviruses. Nucleic Acids Research, 2006,
Vol. 34, No.12.
46. Tanaka, Kuroki, Hamada, Kato, Kinugasa, Shibaguchi, Zhao, Kuroki M.
Cancer-targeting gene therapy using tropism-modified adenovirus.
Anticancer Research 27: 3679-3684 (2007).
47. Tang & Hickey. 2014. Cell cycle and cell division. Nature Publishing
Group. (Available at: : http://www.nature.com/scitable/topic/cell-cycleand-cell-division-14122649 Diakses tanggal: 12 November 2015).
48. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet Tieulent J, Jemal A. 2015.
Global Cancer Statistics, 2012. Ca Cancer J Clin 2015,65:87 108.
49. Van Hagen, Hulshof, van Lanschot, et al. 2012. Preoperative
chemoradiotherapy for esophageal or junctional cancer . N Engl J Med
366;22.
50. Viswanatha D. 2015. Esophagus anatomy. Medscape. (available at:
http://emedicine.medscape.com/article/1948973. Diakses tanggal: 19
November 2015).
51. Viswanathan S, Srinivasan, Prabhu S. 2015. Adenoviruses in gene therapy
A review. Bioengineering and Bioscience 3(1):1 5, 2015.
52. Watanabe N, Shimizu M, Kochi T, Shirakami Y, Tanaka T. 2014.
Esophageal carcinogenesis. Open Journal of Pathology, 2014, 4, 151170.
53. Williams & Stoeber. 2012. The cell cycle and cancer. Journal Of
Pathology 2012; 226: 352 364.
54. Wong, Lemoine, Wang. 2010. Oncolytic viruses for cancer therapy:
Overcoming the obstacles. Viruses 2010, 2, 78 106.
(Available
at:
http://asysyariah.com/kewajiban-menuntut-